Reported 1,300,000 shares, unchanged from the prior quarter.
Reported value 4.0%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 85765000 |
| 2021-12-31 | 66900000 |
| 2022-03-31 | 48255000 |
| 2022-06-30 | 44145000 |
| 2022-09-30 | 30537000 |
| 2022-12-31 | 36153000 |
| 2023-03-31 | 29952000 |
| 2023-06-30 | 38363000 |
| 2023-09-30 | 26819000 |
| 2023-12-31 | 27898000 |
| 2024-03-31 | 26676000 |
| 2024-06-30 | 30186000 |
| 2024-09-30 | 28838700 |
| 2024-12-31 | 20176200 |
| 2025-03-31 | 13459050 |
| 2025-06-30 | 12451100 |
| 2025-09-30 | 12922800 |
| 2025-12-31 | 30378400 |
| 2026-03-31 | 35328000 |
| 2026-06-30 | 52597400 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Added | 2,045,000 | +205,000 (11.1%) | 2.63% | $52,597,400 | 2026-08-14 | |
| Q1 2026 | Unchanged | 1,840,000 | 0 (0.0%) | 2.68% | $35,328,000 | 2026-05-15 | |
| Q4 2025 | Added | 1,840,000 | +950,000 (106.7%) | 1.89% | $30,378,400 | 2026-02-17 | |
| Q3 2025 | Unchanged | 890,000 | 0 (0.0%) | 1.08% | $12,922,800 | 2025-11-14 | |
| Q2 2025 | Reduced | 890,000 | -100,000 (-10.1%) | 1.13% | $12,451,100 | 2025-08-14 | |
| Q1 2025 | Unchanged | 990,000 | 0 (0.0%) | 1.1% | $13,459,050 | 2025-05-15 | |
| Q4 2024 | Unchanged | 990,000 | 0 (0.0%) | 1.34% | $20,176,200 | 2025-02-14 | |
| Q3 2024 | Reduced | 990,000 | -310,000 (-23.8%) | 1.92% | $28,838,700 | 2024-11-14 | |
| Q2 2024 | Unchanged | 1,300,000 | 0 (0.0%) | 2.3% | $30,186,000 | 2024-08-14 | |
| Q1 2024 | Unchanged | 1,300,000 | 0 (0.0%) | 1.98% | $26,676,000 | 2024-05-15 | |
| Q4 2023 | Unchanged | 1,300,000 | 0 (0.0%) | 2.74% | $27,898,000 | 2024-02-14 | |
| Q3 2023 | Unchanged | 1,300,000 | 0 (0.0%) | 2.97% | $26,819,000 | 2023-11-14 | |
| Q2 2023 | Unchanged | 1,300,000 | 0 (0.0%) | 3.35% | $38,363,000 | 2023-08-14 | |
| Q1 2023 | Unchanged | 1,300,000 | 0 (0.0%) | 2.47% | $29,952,000 | 2023-05-15 | |
| Q4 2022 | Added | 1,300,000 | +305,000 (30.7%) | 2.8% | $36,153,000 | 2023-02-14 | |
| Q3 2022 | Reduced | 995,000 | -505,000 (-33.7%) | 2.01% | $30,537,000 | 2022-11-14 | |
| Q2 2022 | Unchanged | 1,500,000 | 0 (0.0%) | 3.73% | $44,145,000 | 2022-08-15 | |
| Q1 2022 | Unchanged | 1,500,000 | 0 (0.0%) | 2.16% | $48,255,000 | 2022-05-16 | |
| Q4 2021 | Reduced | 1,500,000 | -200,000 (-11.8%) | 1.89% | $66,900,000 | 2022-02-14 | |
| Q3 2021 | Added | 1,700,000 | +90,000 (5.6%) | 2.13% | $85,765,000 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
233 managers reported DENALI THERAPEUTICS INC for Q4 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO | Reduced | 14,260,724 | -420,303 | 0.24% | $306,035,137 | 25 qtrs |
| BlackRock Inc | Added | 11,543,446 | +658,150 | < 0.01% | $247,722,351 | 24 qtrs |
| VANGUARD GROUP INC | Added | 10,834,483 | +236,702 | < 0.01% | $232,508,006 | 25 qtrs |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 7,274,717 | -14,243 | 0.03% | $156,115,427 | 6 qtrs |
| Temasek Holdings Private Ltd | Unchanged | 6,895,992 | 0 | 0.83% | $147,987,988 | 25 qtrs |
| Crestline Management LP | Reduced | 5,660,732 | -300,000 | 10.35% | $121,479,309 | 25 qtrs |
| STATE STREET CORPORATION | Added | 5,485,948 | +1,210,620 | < 0.01% | $117,728,444 | 24 qtrs |
| TAKEDA PHARMACEUTICAL CO LTD | New | 4,214,559 | +4,214,559 | 26.55% | $86,946,352 | 1 qtr |
| Capital Research Global Investors | Added | 2,909,528 | +29,205 | 0.02% | $62,438,471 | 6 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 2,659,296 | +127,461 | < 0.01% | $57,075,397 | 24 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2023
- Filed
- February 14, 2024
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 1,300,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.